Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
CLN.WA
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
-0.23
vs -0.10
Q1.23
N/A
-0.19
vs -0.15
Q2.23
+1891%
0.18
vs -0.01
Q3.23
N/A
-0.13
vs -0.01
Q4.23
N/A
-0.29
vs -0.23
Q1.24
N/A
-0.31
vs -0.19
Q2.24
N/A
-0.15
vs 0.18
Q3.24
+894%
1.06
vs -0.13
Q4.24
N/A
-1.39
vs -0.29
Q1.25
N/A
-0.47
vs -0.31
Sales Growth
YoY
Current
Estimates
Q4.22
+13%
44.2M vs 39.2M
Q1.23
+18%
39M vs 32.9M
Q2.23
-8%
42.2M vs 45.8M
Q3.23
+9%
42.5M vs 39M
Q4.23
-8%
40.7M vs 44.2M
Q1.24
-7%
36.3M vs 39M
Q2.24
+27%
53.6M vs 42.2M
Q3.24
+19%
50.7M vs 42.5M
Q4.24
-8%
37.5M vs 40.7M
Q1.25
+34%
48.6M vs 36.3M
Return on Equity
QoQ
Q2.23
+2%
0.02
vs -0.02
Q3.23
-1%
-0.01
vs 0.02
Q4.23
-3%
-0.03
vs -0.01
Q1.24
-4%
-0.04
vs -0.03
Q2.24
-2%
-0.02
vs -0.04
Q3.24
+11%
0.11
vs -0.02
Q4.24
-15%
-0.15
vs 0.11
Q1.25
-6%
-0.06
vs -0.15
Institutionnal Ownership
Relative Strength
CLN.WA
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Forecast
480%2026-Revenue
164%2026-EPS
536%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.
WSE
Unprofitable
Unprofitable
-0.30Â ( -1.28%)
Relative Strenght
Volume Buzz
-84%
Earning Acce
No
Dist 52w H.
30%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How CLN.WA compares to sector?